{
    "thread": {
        "uuid": "8e3d4a20d66eb90ea2ab5a5eb1f5a6d05ec3db13",
        "url": "https://finance.sina.com.cn/roll/2025-04-24/doc-ineufhca2519889.shtml",
        "site_full": "finance.sina.com.cn",
        "site": "sina.com.cn",
        "site_section": "https://finance.sina.cn",
        "site_categories": [
            "tech",
            "top_news_hk",
            "top_news_sg",
            "top_news_tw",
            "top_news"
        ],
        "section_title": "新浪财经_金融信息服务商",
        "site_title": null,
        "title": "欧康维视生物：2024年业绩稳步增长，加强眼科市场领导地位，积极进行股权回购_新浪财经_新浪网",
        "title_full": "欧康维视生物：2024年业绩稳步增长，加强眼科市场领导地位，积极进行股权回购_新浪财经_新浪网",
        "published": "2025-04-24T01:40:00.000+03:00",
        "replies_count": 0,
        "participants_count": 1,
        "site_type": "news",
        "country": "CN",
        "main_image": "",
        "performance_score": 0,
        "domain_rank": 254,
        "domain_rank_updated": "2025-04-22T00:00:00.000+03:00",
        "licensing_agency": [],
        "social": {
            "facebook": {
                "likes": 0,
                "comments": 0,
                "shares": 0
            },
            "vk": {
                "shares": 0
            }
        }
    },
    "uuid": "8e3d4a20d66eb90ea2ab5a5eb1f5a6d05ec3db13",
    "url": "https://finance.sina.com.cn/roll/2025-04-24/doc-ineufhca2519889.shtml",
    "ord_in_thread": 0,
    "author": "sina.com.cn",
    "published": "2025-04-24T01:40:00.000+03:00",
    "title": "欧康维视生物：2024年业绩稳步增长，加强眼科市场领导地位，积极进行股权回购_新浪财经_新浪网",
    "text": "05. 欧康维视生物（01477.HK）2024年业绩交流电话会议：欧康维视生物自2018年底成立以来，已发展成为一个拥有34款产品的公司，其中21款已商业化，在研管线中有3个产品处于三期临床。2024年，公司实现收入4.17亿元，同比增长69.4%，但亏损2.68亿元，较去年有所收窄。公司拥有强大的商业化团队和研发能力，与全球眼科巨头爱尔康达成战略合作，获得8款干眼症治疗和手术用滴眼液产品组合的在华相关权益，进一步巩固其在中国眼科市场的领导地位。此外，公司还积极进行股权回购，截至2025年4月7日，已回购股份1863万股，占回购授权决议通过时已发行股份的2.686%。",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "chinese",
    "sentiment": "positive",
    "categories": [
        "Economy, Business and Finance",
        "Health",
        "Social Issue"
    ],
    "topics": [
        "Economy, Business and Finance->financial and economic news",
        "Economy, Business and Finance->healthcare industry",
        "Health->health treatment and procedure",
        "Health->health organisation",
        "Health->medical condition",
        "Social Issue->demographics",
        "Social Issue->social networking",
        "Social Issue->communities"
    ],
    "ai_allow": true,
    "has_canonical": false,
    "breaking": true,
    "webz_reporter": false,
    "external_links": [],
    "entities": {
        "persons": [],
        "locations": [],
        "organizations": []
    },
    "syndication": {
        "syndicated": null,
        "syndicate_id": null,
        "first_syndicated": false
    },
    "trust": {
        "categories": [],
        "bias": null,
        "source": {
            "type": null,
            "city": null,
            "state": null,
            "country": null,
            "domain_type": null,
            "agency": null,
            "organization_name": null
        }
    },
    "rating": null,
    "crawled": "2025-04-24T01:55:58.114+03:00",
    "updated": "2025-04-24T01:55:58.114+03:00"
}